Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Canada specifies timelines for inspections in new guidance

This article was originally published in The Gold Sheet

Executive Summary

Health Canada has issued a final guidance outlining its policy on the scheduling of inspections. The guidance is called "GMP Inspection Policy for Canadian Drug Establishments" and requires that new establishments should be ready for an inspection when submitting their application for an establishment license (EL). The agency will perform an initial inspection within three months of receiving a request for an EL. The agency warns that if establishments are not prepared for an initial inspection when contacted by the inspectorate, their application will be withdrawn. The new policy went into effect for all inspections scheduled after Jan. 31. The guidance notes that fabricators, packagers, labelers and testing laboratories will be inspected every 24 months, while importers, distributors and wholesalers will be inspected every 36 months

Latest Headlines
See All
UsernamePublicRestriction

Register

PS000242

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel